GUIDED THERAPEUTICS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Guided Therapeutics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Guided Therapeutics Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 56.3K shares.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 56.3K -51M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 55.6K -50.8M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 54.1K -48.5M Dec 31, 2023 10-Q 2024-08-14
Q3 2023 52M* +24.5M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 51M* +23.4M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 50.8M* +28.5M Mar 31, 2023 10-Q 2023-05-15
Q4 2022 48.6M* +34.9M Dec 31, 2022 10-K 2024-03-28
Q3 2022 27.6M +14.4M +110% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 27.6M +27.6M +207338% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 22.3M +22.3M +169217% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 13.7M +535K +4.07% Dec 31, 2021 10-K 2023-03-30
Q3 2021 13.1M +13.1M +111570% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 13.3K +532 +4.17% Jun 30, 2021 10-Q 2021-08-18
Q1 2021 13.2K +1.42K +12% Mar 31, 2021 10-Q/A 2021-08-18
Q4 2020 13.1M +13.1M +395742% Dec 31, 2020 10-K 2022-03-30
Q3 2020 11.8K +9.1K +341% Sep 30, 2020 10-Q/A 2020-11-05
Q2 2020 12.8K +9.45K +285% Jun 30, 2020 10-Q 2020-08-20
Q1 2020 11.8K +8.45K +254% Mar 31, 2020 10-Q 2020-07-07
Q4 2019 3.32K +650 +24.4% Dec 31, 2019 10-K 2021-04-07
Q3 2019 2.67K -382K -99.3% Sep 30, 2019 10-Q 2020-03-09
Q2 2019 3.32K -265K -98.8% Jun 30, 2019 10-Q 2020-02-11
Q1 2019 3.32K -135K -97.6% Mar 31, 2019 10-Q 2019-07-11
Q4 2018 2.67K -46.9K -94.6% Dec 31, 2018 10-K 2020-04-20
Q3 2018 384K +375K +3935% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 268K +266K +10467% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 138K +137K +9593% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 49.6K +48.9K +7309% Dec 31, 2017 10-K 2019-05-08
Q3 2017 9.52K +9.13K +2342% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 2.54K -82.4K -97% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 1.43K -3.9K -73.2% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 669 +666 Dec 31, 2016 10-K/A 2018-04-20
Q3 2016 390 -99.7K -99.6% Sep 30, 2016 10-Q 2016-12-05
Q2 2016 85K -28.3K -25% Jun 30, 2016 10-Q 2016-08-17
Q1 2016 5.32K -94.7K -94.7% Mar 31, 2016 10-Q 2016-05-19
Q4 2015 3* -96.9K Dec 31, 2015 10-K 2017-03-22
Q3 2015 100K -79.3M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 113K +37.8K +50% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 100K +28.3K +39.4% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 96.9K +26.4K +37.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 79.4M* +79.3M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 75.5K +9.42K +14.3% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 71.8K +6.28K +9.59% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 70.5K +8.2K +13.2% Dec 31, 2013 10-K 2015-03-25
Q3 2013 66.3K +4.12K +6.62% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 66.1K +9.91K +17.6% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 65.5K +12.8K +24.3% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 62.3K +10.1K +19.3% Dec 31, 2012 10-K 2014-03-26
Q3 2012 62.2K Sep 30, 2012 10-Q 2012-11-13
Q2 2012 56.2K +7.68K +15.8% Jun 30, 2012 10-Q/A 2012-08-24
Q1 2012 52.7K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 52.2K +4.91K +10.4% Dec 31, 2011 10-K 2013-03-27
Q2 2011 48.5K Jun 30, 2011 10-Q 2011-11-14
Q4 2010 47.3K Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.